*	OR T1 T2
R1	Has_index Arg1:T4 Arg2:T5	
R2	Has_temporal Arg1:T3 Arg2:T4	
*	OR T7 T8
R3	AND Arg1:T6 Arg2:T7	
*	OR T10 T11 T12 T13
R4	AND Arg1:T18 Arg2:T10	
T1	Condition 4 12	pregnant
T2	Condition 16 25	lactating
T3	Observation 28 101	Have participated in any other studies involving investigational products
T4	Temporal 102 147	within 30 days prior to entry into this study
T5	Reference_point 126 146	entry into this stud
T6	Condition 168 193	acute withdrawal syndrome
T7	Drug 199 204	drugs
T8	Drug 208 215	alcohol
T10	Condition 246 259	Schizophrenia
T11	Condition 261 285	Schizoaffective Disorder
T12	Condition 287 312	Schizophreniform Disorder
T13	Condition 316 334	Bipolar I Disorder
T14	Non-query-able 488 671	Have an unstable medical disorder as determined by physical examination or laboratory testing. The primary investigator will be responsible for making this judgment based on the above
T15	Non-query-able 674 781	Had an unsatisfactory response to a previous adequate trial of quetiapine as judged by a study investigator
T17	Non-representable 894 1023	Patients who are currently receiving quetiapine therapy may not undergo a washout period and then restart quetiapine in the study
T18	Procedure 355 421	Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I)
T16	Non-representable 784 891	Patients cannot begin psychotherapy during the study period, but may continue if started prior to the study
